The Role of Metabolic and Environmental Factors in the Formation of Advanced Glycation End Products
Öz
Anahtar Kelimeler
Advanced Glycation End Products, Dietary Habits, Lifestyle Habits
Kaynakça
- Ahmed, N. (2005). Advanced glycation endproducts- Role in pathology of diabetic complications. Diabetes Research and Clinical Practice, 67(1), 3–21. doi:10.1016/j.diabres.2004.09.004
- American Diabetes Association. (2010). Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care, 33(8), 61–78. doi:10.2337/dc10-S061
- Aragno, M., Mastrocola, R. (2017). Dietary sugars and endogenous formation of advanced glycation endproducts: Emerging mechanisms of disease. Nutrients, 9(4), 385-400. doi:10.3390/nu9040385
- Borg, D. J., Forbes, J. M. (2016). Targeting advanced glycation with pharmaceutical agents: where are we now? Glycoconjugate Journal, 33(4), 653–670. doi:10.1007/s10719-016-9691-1
- Byun, K., Yoo, Y. C., Son, M., Lee, J., Jeong, G. B., Park, Y. M., Lee, B. (2017). Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacology and Therapeutics, 177, 44–55. doi:10.1016/j.pharmthera.2017.02.030
- Cai W, He JC, Zhu L, Lu C, Vlassara H. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A 2006;103(37):13801–13806
- Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A. 94(25):13915-13920, 1997.
- Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Cerami, A. (1997). Tobacco smoke is a source of toxic reactive glycation products. Proceedings of the National Academy of Sciences, 94, 13970–13975. doi:10.1073/pnas.94.25.13970
- Chen, H., Virk, M. S., Chen, F. (2016). Phenolic acids inhibit the formation of advanced glycation end products in food simulation systems depending on their reducing powers and structures. International Journal of Food Sciences and Nutrition, 67(4), 400–411. doi:10.3109/09637486.2016.1166187
- CoughlanMT,Thallas-BonkeV,PeteJ,etal.Combinationtherapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergyor redundancy? Endocrinology 2007;148(02): 886–895 83